About 20,000 results
Open links in new tab
  1. Incyte Corporation (INCY) - Yahoo Finance

    Find the latest Incyte Corporation (INCY) stock quote, history, news and other vital information to help you with your stock trading and investing.

  2. INCY Stock Price | Incyte Corp. Stock Quote (U.S.: Nasdaq) | MarketWatch

    4 days ago · INCY | Complete Incyte Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  3. Investors | Incyte

    Jan 5, 2026 · The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts.

  4. Incyte Corp (INCY) Stock Price & News - Google Finance

    Get the latest Incyte Corp (INCY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  5. Incyte (INCY) Stock Price & Overview

    4 days ago · A detailed overview of Incyte Corporation (INCY) stock, including real-time price, chart, key statistics, news, and more.

  6. INCY: Incyte Corp - Stock Price, Quote and News - CNBC

    Feb 6, 2026 · Get Incyte Corp (INCY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

  7. INCY Stock Price Quote | Morningstar

    3 days ago · See the latest Incyte Corp stock price (INCY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

  8. Incyte Corp. Common Stock (INCY) - Nasdaq

    Nov 2, 2025 · Discover real-time Incyte Corp. Common Stock (INCY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

  9. INCY | Incyte Corp. Stock Overview (U.S.: Nasdaq) | Barron's

    Feb 4, 2026 · View real-time INCY stock price and news, along with industry-best analysis.

  10. Incyte (NASDAQ: INCY) surprises with Q4 CY2025 sales - MSN

    Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported in Q4 CY2025, with sales up 27.8% year on year to $1.51 billion. Its non-GAAP profit of $1.80 per share was 6.1% below analysts ...